OVERVIEW

10th Annual Carve Conference is organized by Clinically Relevant Vascular and Endovascular Surgery (CARVE) and would be held during Feb 21 - 23, 2017 at Four Seasons Resort Vail, Vail, Colorado, United States of America. The Target Audience for this Medical Event are Vascular Surgeons, Interventional Radiologists and Cardiologists. This CME conference has been approved with maximum of 20 AMA PRA Category 1 Credits.

Overview
The meeting offers unmatched quality education from clinical best practices to practical approaches in patient care and the business of medicine. Now in its tenth year, this innovative conference will be led by an outstanding international faculty who will offer insightful learning based on real-life lessons, successes and challenges with current surgical and endovascular practice in seven core areas :
• Aortic Aneurysms
• Carotid Occlusive Disease and Stroke
• Interventional Oncology
• Venous Disease
• Peripheral Arterial Disease
• Dialysis Access
• Business and Politics in Healthcare

After completing the program, participants should be able to :
• Explain the latest endovascular treatments for atherosclerotic disease.
• Explain the latest endovascular treatments for aneurysmal disease.
• Describe the latest advances in the diagnosis and treatment of stroke.
• Recognize the latest indication and devices available for IVC filtration.
• Describe open and endo vascular therapies for the creation and maintenance of dialysis access.

KEY DATES

Event Start Date
21 Feb, 2017
Event Start Date
Event End Date
23 Feb, 2017
Event End Date

SPECIALITIES

Cardiology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationFour Seasons Resort Vail
1 Vail Rd

RELATED CONFERENCES & LIVE WEBINARS

Sep 18 - 19, 2026 | Orlando, Florida, USA

State required course for Illinois ...
23 CME/CE
More actions
US$1,695

Sep 24 - 26, 2026 | Dallas, Texas, USA

State required course for Illinois ...
33 CME/CE
More actions
US$2,295

Jul 23 - 25, 2026 | Dallas, Texas, USA

State required course for Illinois ...
34 CE/CME
More actions
US$2,295